Loading Video…
This browser does not support the Video element.
FDA could authorize Novavax COVID-19 vaccine
Novavax is protein-based vaccine, developed with the same technology used to make vaccines for Hepatitis B and shingles.
This browser does not support the Video element.
Novavax is protein-based vaccine, developed with the same technology used to make vaccines for Hepatitis B and shingles.